Covishield and Covaxinare effective against the Indian strain of the coronavirus and show milder illness if infection is contracted after vaccination, reported a senior scientist citing preliminary results of a study.

Anurag Agrawal, Director of the Institute of Genomics and Integrative Biology (IGIB), stated that the study on effectiveness of the vaccines currently available on the B.1.617 variant indicates that the infections are milder following vaccination. The B.1.617 variant has been termed as double mutant or the Indian strain as well.

Another study by the Centre for Cellular and Molecular Biology (CCMB) noted that early results using invitro neutralization assay suggested that both convalescent sera and Covishield-vaccinated sera were protective against the B.1.617 variant… (NDTV – PTI, April 27, 2021)